Searched for
TENOFOVIR
Lupin gets tentative nod from USFDA for generic HIV treatment drugLupin Ltd. has received tentative USFDA approval for its generic Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets (50 mg/200 m...- Strides Pharma gets USFDA nod to market HIV drugThe company's product is bioequivalent and therapeutically equivalent to Atripla Tablets of Gilead Sciences LLC, it added. As per per IQVIA...
- How a drug major profited by slow-walking a promising HIV therapyToday, a generation of expensive Gilead drugs containing the new iteration of tenofovir account for half of the market for HIV treatment an...
- Lupin gets USFDA nod to market drug used to treat chronic hepatitis BThe company has received tentative approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug applicat...
- Zydus Cadila gets USFDA nod to market generic HIV infection treatment tabletsThe drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad. The drug is used with other HIV medicati...
- Lupin launches generic HIV-1 drug in USThe drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...
- Lupin gets USFDA nod to market generic HIV drugThe company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Dis...
- Strides Pharma Science arm gets USFDA nod for HIV treatment drugDrug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from th...
- NPPA seeks clarification on Gilead's drug pricing pleaNational Pharmaceutical Pricing Authority has sought clarifications from the company. Gilead had sought exemption from price control for it...
- Cipla gets USFDA approval for HIV drugCiting IMS Health data, the company said Viread Tablets, 300mg, had US sales of approximately USD 725 million for the 12-month period endin...
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...
- Aurobindo Pharma gets USFDA nod for anti-HIV drugAurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, use...
- Cipla ready to launch low dose HIV drug 'Efavirenz'Drug major Cipla Ltd today said it is ready to launch low dose 'Efavirenz' used in treatment of HIV infection.
- HIV breakthrough: FDA approves new drug with fewer side effectsA new treatment for HIV infection has been approved by US federal regulators which does not have the side effects associated with other dru...
- Cipla gets USFDA nod for HIV drugCipla said that it has received the US regulator's approval for Tenofovir disoproxil fumarate tablets used for treating HIV-1 infection in ...
- Ranbaxy in pact with Gilead for 'Tenofovir'Ranbaxy Laboratories Ltd said on Monday that it has entered into a licensing agreement with US-based Gilead Sciences Inc for manufacturing ...
- JB Chem ties up with US co for anti-HIV drugJB Chemicals & Pharmaceuticals Ltd on Friday said it has signed a non-exclusive license agreement with US-based Gilead Sciences Inc to manu...
- Matrix signs licensing deal with US coPharmacuetical company, Matrix Laboratories Ltd on Friday said it signed a licensing agreement with Gilead for manufacture and sale of a ge...
- AIDS drug Tenofovir price set to crashBlockbuster AIDS drug Tenofovir is set to get cheaper after its inventor and US patent holder Gilead struck non-exclusive licensing deals w...
- AIDS drug Viread prices may dip soonBlockbuster AIDS drug Viread is set to witness a price war in the domestic market in the next few days, benefitting lakhs of patients using...
Load More
